E
Eli Magen
Researcher at Ben-Gurion University of the Negev
Publications - 94
Citations - 1994
Eli Magen is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 79 publications receiving 1493 citations. Previous affiliations of Eli Magen include Barzilai Medical Center & Clalit Health Services.
Papers
More filters
Journal ArticleDOI
Copper Oxide Impregnated Textiles with Potent Biocidal Activities
TL;DR: Data is described showing that antifungal socks containing 10% w/w (weight/weight) copper-impregnated fibers alleviate athlete’s foot; antimicrobial fabrics (sheets) containing 10%, decrease bacterial colonization in a clinical setting; and these products do not have skin-sensitizing properties or any other adverse effects, demonstrate the wide preventive and curative potential of copper oxide-Impregnated apparel products.
Journal ArticleDOI
CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
TL;DR: CTLA-4 is upregulated during HIV infection and may account for CD4 T-cell decline and anergy in HIV-1 infection and offer a novel approach for immune-based therapy in HIV infection.
Journal ArticleDOI
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
Ariel Israel,Eugene Merzon,Alejandro A. Schäffer,Yotam Shenhar,Ilan Green,Avivit Golan-Cohen,Eytan Ruppin,Eli Magen,Shlomo Vinker +8 more
TL;DR: In this paper, a large population of adults tested for SARS-CoV-2 by RT-PCR after two doses of mRNA BNT162b2 vaccine, a gradual increase in the risk of infection was seen for individuals who received their second vaccine dose after at least 90 days.
Journal ArticleDOI
End tidal carbon dioxide as a predictor of the arterial Pco2 in the emergency department setting
TL;DR: Young age may increase the arterial Pco2/SSETCO2 gradient while raised temperature may decrease this gradient, and further studies are needed to confirm these findings in the normal healthy population.
Posted ContentDOI
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Ariel Israel,Yotam Shenhar,Ilan Green,Eugene Merzon,Avivit Golan-Cohen,Alejandro A. Schäffer,Eytan Ruppin,Shlomo Vinker,Eli Magen +8 more
TL;DR: In this article, the authors measured the kinetics of SARS-CoV-2 IgG antibodies following administration of two doses of BNT162b2 vaccine, or infection in unvaccinated individuals.